Skip to content

A Disease Management Study Targeted to Reduce Health Care Utilization for Patients With Congestive Heart Failure

A Disease Management Study Targeted to Reduce Health Care Utilization for Patients With Congestive Heart Failure

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02251899
Enrollment
10000
Registered
2014-09-29
Start date
2010-01-31
Completion date
2016-06-30
Last updated
2015-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Focus is to Investigate Effects of a Disease Management Intervention for Patients With Congestive Heart Failure

Brief summary

The aim of this study is to determine whether a nurse-managed telephone-based disease-management intervention can reduce healthcare utilization and improve self-assessed health status in patients with congestive heart failure.

Interventions

BEHAVIORALDisease-Management intervention

The participants in the intervention group receive a nurse-managed disease-management intervention that is regularly delivered by telephone or, when necessary, in person

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Ostergotland County Council, Sweden
CollaboratorOTHER
Vastra Gotaland Region
CollaboratorOTHER_GOV
Uppsala County Council, Sweden
CollaboratorOTHER_GOV
Health Navigator
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with ≥1 unplanned inpatient occasion with primary diagnosis of heart failure ( I50) during the last 12 months * Heart failure grade NYHA II- III * Accurate heart failure diagnosis * Living in one of four Swedish counties where the trial is ongoing

Exclusion criteria

* Deceased * In a moribund state * Significant cognitive loss and therefore cannot provide consent * Psychosis diagnosis * Severe hearing impairment * Language difficulties * Participants in another study

Design outcomes

Primary

MeasureTime frame
Number of hospitalizationsFrom randomization for up to 2 years
Number of outpatient visits to medical doctorFrom randomization for up to 2 years

Secondary

MeasureTime frame
MortalityFrom randomization for up to 2 years
Length of hospital staysFrom randomization for up to 2 years
Total health care costFrom randomization for up to 2 years

Countries

Sweden

Contacts

Primary ContactGustaf Edgren
gustaf@pheph.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026